Veterans' skin cancer shield: cream may stop new tumors
NCT ID NCT05212246
First seen Jan 23, 2026 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This study tests whether a cream called imiquimod can prevent new basal cell carcinomas (a common skin cancer) on the face of veterans who have already had two or more such cancers. About 1,630 high-risk veterans will apply either the active cream or a placebo to their face daily for 12 weeks. Researchers will then track how many develop new facial skin cancers over the next one to three years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Providence VA Medical Center, Providence, RI
Providence, Rhode Island, 02908-4734, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.